Corteva (NYSE:CTVA) Stock Price Expected to Rise, Mizuho Analyst Says

Corteva (NYSE:CTVA) had its price target increased by stock analysts at Mizuho from $80.00 to $82.00 in a research note issued on Tuesday, Marketbeat Ratings reports. The brokerage currently has an “outperform” rating on the stock. Mizuho’s price objective indicates a potential upside of 7.05% from the company’s current price.

Other research analysts also recently issued reports about the company. Bank of America increased their target price on Corteva from $80.00 to $82.00 and gave the company a “buy” rating in a research report on Thursday, January 8th. Royal Bank Of Canada increased their price objective on shares of Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. The Goldman Sachs Group restated a “buy” rating and issued a $88.00 target price on shares of Corteva in a report on Thursday, February 5th. Zacks Research raised shares of Corteva from a “hold” rating to a “strong-buy” rating in a report on Thursday, January 22nd. Finally, Rothschild & Co Redburn dropped their price target on Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a research report on Tuesday, November 11th. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, Corteva presently has an average rating of “Moderate Buy” and an average price target of $82.30.

Corteva Stock Up 1.4%

Shares of CTVA stock opened at $76.60 on Tuesday. The company’s fifty day simple moving average is $70.29 and its two-hundred day simple moving average is $68.52. Corteva has a 52 week low of $53.40 and a 52 week high of $77.41. The stock has a market cap of $51.52 billion, a P/E ratio of 48.48, a PEG ratio of 2.57 and a beta of 0.75. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last issued its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. The firm had revenue of $3.91 billion during the quarter, compared to analyst estimates of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business’s quarterly revenue was down 1.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts predict that Corteva will post 2.96 EPS for the current fiscal year.

Hedge Funds Weigh In On Corteva

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Brighton Jones LLC raised its stake in shares of Corteva by 307.2% in the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after purchasing an additional 11,760 shares during the last quarter. Woodline Partners LP increased its holdings in Corteva by 40.3% in the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after buying an additional 16,644 shares during the period. Allspring Global Investments Holdings LLC raised its position in Corteva by 3.0% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 49,087 shares of the company’s stock worth $3,687,000 after buying an additional 1,419 shares during the last quarter. Harbour Investments Inc. lifted its stake in Corteva by 13.6% during the 2nd quarter. Harbour Investments Inc. now owns 2,737 shares of the company’s stock valued at $204,000 after acquiring an additional 328 shares during the period. Finally, Nordea Investment Management AB boosted its holdings in shares of Corteva by 1.9% in the 2nd quarter. Nordea Investment Management AB now owns 59,414 shares of the company’s stock valued at $4,416,000 after acquiring an additional 1,124 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.